Ingrezza (valbenazine) is a VMAT2 inhibitor that's used to treat tardive dyskinesia (TD) in adults. It can also treat chorea (random muscle movements) in adults with Huntington's disease. Ingrezza (valbenazine) is a capsule that's convenient to take because the dosing is typically once per day by mouth. But this medication can have side effects, like sleepiness, fatigue, and other movement problems (e.g., parkinsonism).
Ingrezza (valbenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor. It's not exactly known how the medication helps with movement problems, but it's thought to block the VMAT2 protein in your brain. This lowers the amount of certain chemicals, like dopamine and serotonin, that are released in the brain and are involved with movements of your body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Tardive dyskinesia:
Chorea from Huntington's disease:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
More tips for Ingrezza Sprinkle (valbenazine) capsules:
No, Ingrezza (valbenazine) isn't a controlled substance. This medication doesn't have a risk of misuse or dependence.
No, Ingrezza (valbenazine) doesn't cause tardive dyskinesia (TD), which is when you have uncontrollable muscle movements. Instead, it actually helps treat TD. But this medication can cause other movement problems called parkinsonism as a side effect. Parkinsonism are abnormal movements, such as a tremor, slow movement, impaired speech, muscle stiffness, and loss of balance. Talk to your prescriber if you have any unusual movements after you start Ingrezza (valbenazine).
Studies show that people taking Ingrezza (valbenazine) for TD or chorea from Huntington's disease started to see improvement in symptoms in as little as 2 weeks. But it can take up to 6 weeks for some people with TD and up to 12 weeks for some people with chorea from Huntington's disease to get the maximum benefit from Ingrezza (valbenazine). Keep in mind that everyone can respond differently to the medication. Talk to your prescriber if you're concerned with how well Ingrezza (valbenazine) is working for you.
It's not clear whether the Ingrezza (valbenazine) capsules can be opened or not. But you can open the Ingrezza Sprinkle (valbenazine) capsules. Pour all the granules inside the Ingrezza Sprinkle capsule in a bowl with about 1 tablespoon of soft food (for example, applesauce, yogurt, or pudding); don't mix with milk or drinking water. Stir the medication into the soft food with a spoon. Once stirred well, swallow the mixture right away and drink a glass of water afterwards. Ask your prescriber about switching to the Ingrezza Sprinkle capsules if you're having trouble swallowing capsules whole.
Weight gain is a possible side effect of Ingrezza (valbenazine), but it's not common. Only up to 1% of people who took Ingrezza (valbenazine) reported weight gain in clinical studies. To lower your risk for weight gain while you're taking this medication, make sure to eat a balanced and nutritious diet and regularly exercise. Contact your prescriber or primary care provider if you notice significant changes in weight while you're taking Ingrezza (valbenazine).
It takes about 3 to 4.5 days for most of Ingrezza (valbenazine) to leave your body after a single dose. This time frame is estimated based on the half-life of Ingrezza (valbenazine). Keep in mind that how long the medication stays in your system can depend on your genetics, among some other factors.
Yes, Ingrezza (valbenazine) is a specialty medication. This means that the medication isn't typically available at your local pharmacy, but through a specialty pharmacy. You'll usually have the option of having your medication mailed directly to you. Talk to your prescriber if you have questions on how to get Ingrezza (valbenazine).
No, Ingrezza (valbenazine) isn't an antipsychotic and it doesn't help treat mental health problems, like bipolar disorder or schizophrenia. Ingrezza (valbenazine) is a medication that can help treat a possible side effect of antipsychotics called tardive dyskinesia (TD). Ask your prescriber whether Ingrezza (valbenazine) is right for you if you start having TD from any antipsychotics that you might be taking.
Ingrezza (valbenazine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Ingrezza (valbenazine) can raise the risk of depression and thoughts of suicide or harming yourself, especially in people with Huntington's disease. Your prescriber might screen you for depression and suicidal thoughts throughout your treatment. Call a healthcare professional right away if you or a loved one notices that you have signs of depression, suicidal thoughts, or unusual behavior (e.g., anxiety, panic attacks, difficulty sleeping, feeling angry or irritated) while you're taking Ingrezza (valbenazine).
Serious allergic reactions to Ingrezza (valbenazine) are possible, including life-threatening reactions like swelling of the throat. Get medical attention right away if you notice dizziness; nausea; a choking sensation; trouble breathing; swelling of the lips, tongue, around the eyes, or face after you take Ingrezza (valbenazine).
Ingrezza (valbenazine) can make you sleepy, which can affect your ability to focus, think, or react. This side effect is more likely to happen or be more intense if you drink alcohol while you're taking Ingrezza (valbenazine) or if you take other medications that cause sleepiness (e.g., opioids, benzodiazepines). Don't drive or operate machinery until you know how Ingrezza (valbenazine) affects you.
Although rare, Ingrezza (valbenazine) might lengthen the time period from when the heart squeezes and then relaxes. This is known as QT prolongation. When this happens, it raises the risk for life-threatening abnormal heart rhythms. Your risk of QT prolongation is greater if you take Ingrezza (valbenazine) with other medication(s) that cause QT prolongation or medications that interact with Ingrezza (valbenazine).
Make sure to tell your prescriber about your medical history. People who were born with QT prolongation or have a history of arrhythmias should avoid taking Ingrezza (valbenazine). Also be sure to tell your healthcare team about all the medications you're taking. Don't start any new medications while you're taking Ingrezza (valbenazine) without talking to your prescriber or pharmacist first.
Your prescriber might order tests to check your heart if you're at risk for QT prolongation. Call 911 right away if you feel your chest pounding, short of breath, chest pain, feeling faint, or lightheaded while you're taking Ingrezza (valbenazine).
Taking Ingrezza (valbenazine) can potentially lead to a rare, but life-threatening condition called neuroleptic malignant syndrome (NMS). Symptoms include high fever, sweating, stiff muscles, confusion, not being aware of your surroundings, and fast or irregular heartbeat. Your risk is higher if you take other medications that can cause NMS, such as antipsychotics (e.g., haloperidol (Haldol), risperidone (Risperdal), olanzapine (Zyprexa)). Get medical attention as soon as possible if you have any symptoms of NMS while you're taking Ingrezza (valbenazine). You'll probably have to stop taking Ingrezza (valbenazine) and switch to another medication.
Ingrezza (valbenazine) might cause parkinsonism, or abnormal movements such as a tremor, slow movement, impaired speech, muscle stiffness, and loss of balance. These abnormal movements can lead to falls. In most reported cases, any severe parkinsonism happened within the first two weeks after starting or raising the dose of Ingrezza (valbenazine). This problem typically went away after lowering the dose or stopping the medication. Tell your healthcare team if you experience any of these abnormal movements while you're taking Ingrezza (valbenazine). You'll probably have to stop taking the medication if your abnormal movements still don't get better.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 28 tablets of 40mg and 80mg | 1 dose pack | $8,461.94 | $8,461.94 |
The typical starting dose is 40 mg by mouth once per day. Depending on how you tolerate and respond to the medication, the dose will slowly be raised up to the recommended dose of 80 mg once per day.
Your dose might differ if you have liver problems, if you take other medications that interact with Ingrezza (valbenazine), or if you have certain genetics that will affect the levels of Ingrezza (valbenazine) in your body.